Neuromodulation Devices
•26 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (26)
| Company | Market Cap | Price |
|---|---|---|
|
BSX
Boston Scientific Corporation
Neuromodulation devices including Intracept intraosseous nerve ablation system.
|
$149.60B |
$100.97
-0.39%
|
|
SYK
Stryker Corporation
OptaBlate BVN system is a neuromodulation/pain-management device.
|
$142.33B |
$372.28
-0.75%
|
|
MDT
Medtronic plc
Neuromodulation Devices cover the spine and brain stimulation technologies (e.g., Inceptiv, Percept) highlighted in the pipeline.
|
$134.71B |
$105.02
-0.31%
|
|
GMED
Globus Medical, Inc.
Neuromodulation devices via Nevro spinal cord stimulation platform and expansion.
|
$12.30B |
$91.05
-0.14%
|
|
INSP
Inspire Medical Systems, Inc.
Inspire V is a neuromodulation device designed to treat obstructive sleep apnea, representing Inspire's core product category.
|
$3.77B |
$127.50
-2.22%
|
|
LIVN
LivaNova PLC
Directly manufactures/distributes Neuromodulation Devices, including VNS Therapy and proximal hypoglossal nerve stimulation systems.
|
$3.49B |
$63.78
+0.74%
|
|
ATEC
Alphatec Holdings, Inc.
SafeOp neural monitoring systems used during spine surgery.
|
$3.34B |
$22.61
+3.55%
|
|
ITGR
Integer Holdings Corporation
Neuromodulation devices are a high-growth served market for Integer and align with its product portfolio.
|
$2.52B |
$72.09
+0.92%
|
|
PCRX
Pacira BioSciences, Inc.
IOvera's mechanism relates to neuromodulation/nerve-targeted therapy, aligning with Neuromodulation Devices.
|
$1.07B |
$23.82
+2.78%
|
|
BVS
Bioventus Inc.
Peripheral Nerve Stimulation products (TalisMann, StimTrial) are neuromodulation devices.
|
$632.49M |
$7.65
-1.80%
|
|
AVNS
Avanos Medical, Inc.
The RFA portfolio (ESENTEC, TRIDENT, COOLIEF) places Avanos in the neuromodulation devices category.
|
$549.41M |
$11.86
-0.96%
|
|
NPCE
NeuroPace, Inc.
Core product Neuromodulation device (RNS System) delivering brain-responsive, on-demand therapy for drug-resistant epilepsy.
|
$545.84M |
$16.53
-1.02%
|
|
OBIO
Orchestra BioMed Holdings, Inc.
AVIM therapy uses neuromodulation to affect autonomic nervous system responses, fitting Neuromodulation Devices.
|
$282.72M |
$5.21
-2.62%
|
|
BWAY
BrainsWay Ltd.
Core product: BrainsWay's Deep TMS neuromodulation devices.
|
$263.11M |
$15.66
+1.69%
|
|
CVRX
CVRx, Inc.
CVRx's Barostim is a neuromodulation device (implantable) that modulates the autonomic nervous system via baroreflex activation for heart failure.
|
$257.07M |
$9.87
-1.20%
|
|
NYXH
Nyxoah S.A.
Genio is a neuromodulation implant system (implantable medical device) for obstructive sleep apnea.
|
$160.60M |
$4.60
+0.66%
|
|
STIM
Neuronetics, Inc.
NeuroStar Advanced Therapy System is a non-invasive neuromodulation device; the direct product of the company.
|
$91.91M |
$1.39
+1.09%
|
|
VANI
Vivani Medical, Inc.
Vivani's Neurostimulation division (Cortigent) assets exist and are being spun off, representing Neuromodulation Devices.
|
$80.57M |
$1.36
+3.41%
|
|
ZYXI
Zynex, Inc.
NexWave and TensWave are neuromodulation/electrotherapy devices, placing the company in the neuromodulation devices category.
|
$48.17M |
$1.58
+114.27%
|
|
ECOR
electroCore, Inc.
Directly markets and sells neuromodulation medical devices (gammaCore, Quell, Truvaga, Sparrow Ascent, TAC-STIM).
|
$37.16M |
$4.97
+0.91%
|
|
NMTC
NeuroOne Medical Technologies Corporation
Core product category: neuromodulation devices used to treat epilepsy and pain via brain stimulation and ablation.
|
$34.86M |
$0.71
+3.77%
|
|
NRXS
NeurAxis, Inc.
Core product line: Neuromodulation devices (IB-Stim PENFS).
|
$26.32M |
$2.71
+2.08%
|
|
NXL
Nexalin Technology, Inc.
Core product is non-invasive neuromodulation devices for brain stimulation (Gen-2 SYNC, Gen-3 HALO).
|
$18.81M |
$1.09
+3.30%
|
|
COCH
Envoy Medical, Inc.
Cochlear implants operate by neuromodulating auditory pathways, classifying them as neuromodulation devices.
|
$17.19M |
$0.80
-0.05%
|
|
AMIX
Autonomix Medical, Inc. Common Stock
Core platform is a catheter-based Neuromodulation Device designed to sense and ablate peripheral nerves.
|
$5.45M |
$1.07
+11.23%
|
|
HSDT
Solana Company
PoNS is a non-invasive neuromodulation device produced by the company for gait and balance rehabilitation.
|
$4.32M |
$4.01
+11.70%
|
Loading company comparison...
Loading industry trends...
Loading research report...
